GE HealthCare Technologies Inc. (GEHC)
NASDAQ: GEHC · Real-Time Price · USD
69.37
-1.16 (-1.64%)
May 5, 2025, 4:00 PM EDT - Market closed
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Product | 13.08B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Product Growth | -0.40% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Service | 6.60B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Service Growth | 2.68% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Imaging Revenue (Post-Q2 2024) | 8.86B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Imaging Revenue (Post-Q2 2024) Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Advanced Visualization Solutions (AVS) | 5.13B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Advanced Visualization Solutions (AVS) Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Patient Care Solutions (PCS) | 3.13B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Patient Care Solutions (PCS) Growth | -0.54% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical Diagnostics (PDx) | 2.51B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical Diagnostics (PDx) Growth | 8.76% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 52.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | -21.21% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Imaging | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Imaging Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Ultrasound | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Ultrasound Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBIT by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Imaging EBIT (Post-Q2 2024) | 962.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Imaging EBIT (Post-Q2 2024) Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Advanced Visualization Solutions (AVS) EBIT | 1.12B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Advanced Visualization Solutions (AVS) EBIT Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Patient Care Solutions (PCS) Segment EBIT | 347.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Patient Care Solutions (PCS) Segment EBIT Growth | -9.40% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical Diagnostics (PDx) Segment EBIT | 783.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical Diagnostics (PDx) Segment EBIT Growth | 26.90% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Segment EBIT | 2.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Segment EBIT Growth | -81.82% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Imaging Segment EBIT | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Imaging Segment EBIT Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Ultrasound Segment EBIT | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Ultrasound Segment EBIT Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| USCAN | 8.98B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| USCAN Growth | 5.03% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| EMEA | 5.05B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| EMEA Growth | -0.14% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China | 2.36B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | -15.26% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of World | 3.28B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of World Growth | 3.86% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Products Remaining Performance Obligations (RPO) | 4.76B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Products Remaining Performance Obligations (RPO) Growth | -3.55% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Services Remaining Performance Obligations (RPO) | 9.74B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Services Remaining Performance Obligations (RPO) Growth | 0.12% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total Remaining Performance Obligations (RPO) | 14.49B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total Remaining Performance Obligations (RPO) Growth | -1.12% |
Log In |
Log In |
Log In |
Log In | Upgrade
|